De Novo Pathway
  • Home
    • De Novo Pathway
Categories
Recent Posts
Synthesis of Therapeutic OligonucleotidesSynthesis of Therapeutic Oligonucleotides
What Are Small Nucleic Acid Drugs?What Are Small Nucleic Acid Drugs?
Controllable Synthesis of RNA Oligonucleotides Without TemplatesControllable Synthesis of RNA Oligonucleotides Without Templates
Sugar: Coordinator of Plant Defense SignalingSugar: Coordinator of Plant Defense Signaling

De Novo Pathway

<i>De Novo</i> and Salvage Synthesis Pathways of Purine Nucleotides
October 11, 2024
De Novo and Salvage Synthesis Pathways of Purine Nucleotides

As the basic components of RNA and DNA, purine nucleotides play an important role in cellular material metabolism and energy metabolism. For this reason, cells need an adequate supply of purine nucleotides to meet the needs of growth and proliferation. However, we still do not know how normal or malignant tumor tissues maintain nucleotide metabolic […]

Read More >
New Strategy for Nucleotide Sugar Synthesis - Engineering Yeast to Synthesize 7 UDP-Sugars
September 20, 2024
New Strategy for Nucleotide Sugar Synthesis - Engineering Yeast to Synthesize 7 UDP-Sugars

Nucleotide Sugar is an activated form in the process of sugar conversion and synthesis, widely present in eukaryotes and prokaryotes. It is essential for the operation of physiological functions and even survival of organisms as a glycosyl donor in polysaccharide synthesis. Structurally, nucleotide sugars can be divided into nucleoside monophosphate (NMP)-sugar and nucleotide diphosphate (NDP)-sugar, […]

Read More >

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Important Links

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0